In decentralized clinical trials, studies are being carried out using electronic patient reported outcomes (ePRO/surveys), eConsent, text messages, drug kits sent by mail, patient directed data sharing, and more. These tools greatly improve the patient experience and advance the traditional clinical trial model.
Decentralized clinical trials were on the rise before COVID-19, but their success in keeping drug development programs on track during the pandemic won these studies a renewed, leading role in mainstream clinical research. We’ve seen this type of digital transformation in many other areas. It’s akin to what Venmo did for exchanging funds and QR codes have done for restaurant menus. These examples show that as digital, cloud-based tools and technology make their way into the mainstream, the benefits are tangible. And it’s no different for clinical research.